Slovakya -
Slovakça -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
gemcitabín sun 10 mg/ml infúzny roztok
sun pharmaceutical industries europe b.v. , holandsko - gemcitabín - 44 - cytostatica
Slovakya -
Slovakça -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
fyremadel 0,25 mg/0,5 ml injekčný roztok v naplnenej injekčnej striekačke
sun pharmaceutical industries europe b.v. , holandsko - ganirelix - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
Avrupa Birliği -
Slovakça -
EMA (European Medicines Agency)
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastické činidlá - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
Avrupa Birliği -
Slovakça -
EMA (European Medicines Agency)
odomzo
sun pharmaceutical industries europe b.v. - sonifegib difosfát - karcinóm, bazálna bunka - antineoplastické činidlá - odomzo je indikovaný na liečbu dospelých pacientov s lokálne pokročilým bazocelulárny karcinóm (bcc), ktorí nie sú ochotná liečebný chirurgie alebo radiačnej terapie.
Avrupa Birliği -
Slovakça -
EMA (European Medicines Agency)
sunlenca
gilead sciences ireland unlimited company - lenacapavir sodium - hiv infekcie - antivirotiká na systémové použitie - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 a 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 a 5.
Slovakya -
Slovakça -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
sunitinib mylan 50 mg
mylan ireland limited, Írsko - sunitinib - 44 - cytostatica
Slovakya -
Slovakça -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
sunitinib mylan 37,5 mg
mylan ireland limited, Írsko - sunitinib - 44 - cytostatica
Slovakya -
Slovakça -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
sunitinib mylan 25 mg
mylan ireland limited, Írsko - sunitinib - 44 - cytostatica
Slovakya -
Slovakça -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
sunitinib mylan 12,5 mg
mylan ireland limited, Írsko - sunitinib - 44 - cytostatica
Slovakya -
Slovakça -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
sunitinib teva 50 mg tvrdé kapsuly
teva b.v., holandsko - sunitinib - 44 - cytostatica